ADIPOQ and chronic obstructive pulmonary disease: Daniele et al. have demonstrated that the oligomerization pattern of adiponectin is altered in COPD; in particular the higher levels of adiponectin are associated with a specific increase of high molecular weight adiponectin, the most biologically active isoform [123].